EMB-001

DRUG3 trials

Sponsors

Embera NeuroTherapeutics, Inc.

Conditions

Cocaine Use DisorderTobacco Use Disorder

Phase 1

A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

CompletedNCT02856854

Embera NeuroTherapeutics, Inc.Cocaine Use Disorder

Start: 2016-07-31End: 2017-07-25Updated: 2017-08-01

Study of EMB-001 as a Potential Smoking Cessation Treatment

TerminatedNCT04933916

Embera NeuroTherapeutics, Inc.Tobacco Use Disorder

Start: 2021-06-10End: 2023-05-01Updated: 2023-08-09

Phase 2

A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder

CompletedNCT04501874

Embera NeuroTherapeutics, Inc.Cocaine Use Disorder

Start: 2020-07-29End: 2022-10-15Updated: 2023-08-08